SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
38
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in GreenSky, Inc. of Class Action Lawsuit and Upcoming Deadline – GSKY

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against, GreenSky, Inc. (“GreenSky” or the “Company”) (NASDAQ: GSKY) and certain of its officers.   The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-00100, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise, acquired GreenSky Class A common stock pursuant or traceable to the Company’s false and misleading registration statement and prospectus, who were damaged thereby, and who seek to pursue remedies under the Securities Act of 1933 (“Securities Act”).

If you are a shareholder who purchased GreenSky Class A common stock pursuant or traceable to the Company’s registration statement and prospectus, you have until January 28, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

[Click here to join this class action]

GreenSky is a financial technology company in Atlanta, Georgia, and runs an online platform that allows creditors to process loan applications at the point of sale.  GreenSky’s platform is actively used by over 10,000 businesses. Consumers use GreenSky’s mobile app to make purchases from those listed business by applying for on-the-spot financing via the app.

GreenSky’s two principal sources of revenue are: (i) “transaction fees” the Company receives upfront when a consumer secures a loan through the GreenSky platform and makes a purchase; and (ii) recurring fees generated from banks over the lives of loans it facilitates. Transaction fees are critical to GreenSky’s business. For example, transaction fees accounted for 87% of the Company’s revenue in 2017. These transaction fees vary per the particular agreement between GreenSky and a merchant.

On April 27, 2018, GreenSky filed a registration statement. Then, on May 25, 2018, GreenSky filed a prospectus for its upcoming initial public offering (“IPO”). GreenSky’s registration statement and prospectus are referred to herein as the “Offering Documents.”

On May 29, 2018, GreenSky’s IPO closed and the Company sold 43.7 million shares of Class A common stock at $23.00 per share in its IPO, for gross proceeds of over $1 billion.

The complaint alleges that The Offering Documents were negligently prepared and, as a result, contained untrue statements of material facts or omitted to state other facts necessary to make the statements made not misleading, and were not prepared in accordance with the rules and regulations governing their preparation as the Offering Documents failed to disclose: (i) that GreenSky was transitioning away from the solar power market in favor of the elective healthcare market; (ii) foreseeable negative effects on GreenSky’s profits because of significant differences in transaction fees GreenSky charged to different classes of merchants; (iii) the primacy of the merchant mix as a driver of GreenSky’s transaction-fee revenue; (iv) the ongoing deterioration in GreenSky’s transaction-fee revenue, while touting GreenSky’s growth and financial performance; (v) the negative impacts of GreenSky’s changing merchant mix on EBITDA; (vi) the markedly lower transaction fees GreenSky charges to healthcare companies; and (vii) as a result of the foregoing, GreenSky’s Offering Documents were materially false and misleading at all relevant times.

On August 7, 2018, GreenSky issued a release announcing its financial results for the second quarter of 2018. The release indicated that the Company’s transaction-fee rate was approximately 53 basis points below the rate achieved in the second quarter of 2017.  In an earnings call, Defendant Zalik acknowledged that this rapid reduction was attributable to the transition away from solar panel merchants and toward elective healthcare companies.

On November 6, 2018, GreenSky lowered its full-year 2018 transaction volume guidance from between $5.1 and $5.3 billion to between $4.9 and $5.1 billion and lowered its full-year 2018 Adjusted EBITDA guidance from between $192 and $199 million to between $165 and $175 million.  GreenSky attributed the reduction to a general labor shortage and unfavorable shifts in its loan mix. 

Following these disclosures, GreenSky’s stock price closed at $9.28 per share, a decline of $13.72, or approximately 60%, from the IPO price of $23.00 per share.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com 888-476-6529 ext. 9980

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Shift at Tourmaline Bio: CMO Resignation Announced

Updated Category News Views 119

Leadership Transition at Tourmaline Bio Tourmaline Bio, Inc. (NASDAQ:TRML) has recently revealed a significant change within its leadership. Dr. Yung Chyung, the Chief Medical Officer (CMO), is set to resign from his post effective at the end of October. This announcement took place in a recent filing, highlighting the company's commitment to transparency as it reshapes...

Continue Reading
Innovative Cancer Research by Compugen at Upcoming Conference

Updated Category News Views 118

Compugen to Showcase Groundbreaking Research in Cancer Immunotherapy Compugen Ltd. (Nasdaq: CGEN), a leading force in clinical-stage cancer immunotherapy, has announced an exciting opportunity to present at the upcoming Single Cell Genomics 2025 Conference. This event, scheduled for September 15-17, highlights advancements in genomics and how it intertwines with cancer...

Continue Reading
Transform Your Finances: The Journey of Salesforce Stock

Updated Category News Views 222

Transformational Growth of Salesforce Stock Over the past 15 years, Salesforce (NYSE: CRM) has emerged as a powerhouse in the tech industry, consistently surpassing market expectations. With an impressive average annual return rate of 22.25%, it has outperformed the broader market by 10.15% on an annualized basis. As of now, the company's market capitalization stands at...

Continue Reading
Infosys and AGCO Join Forces for Transformational Success

Updated Category News Views 185

Infosys and AGCO Team Up for IT and HR Transformation Building on a longstanding relationship to enhance AGCO's operational framework for growth by leveraging Infosys Cobalt and Infosys Topaz. Infosys (NSE: INFY), a global leader in next-generation digital services and consulting, has announced the continuation of its strategic partnership with AGCO Corporation (NYSE:...

Continue Reading
Transforming Europe's Contract Furniture Market with AI Strategies

Updated Category News Views 385

Growth of Europe's Contract Furniture Market The contract furniture and furnishing market in Europe is on the verge of a substantial transformation, anticipating an impressive growth of USD 4.75 billion from 2024 to 2028. The compound annual growth rate (CAGR) is expected to be close to 5.1% during this forecast period. This expansion is mainly driven by the increasing...

Continue Reading